Skip to main content
. 2021 Nov;157:308–347. doi: 10.1016/j.ejca.2021.07.039

Appendix Table A4.

Estimated numbers of deaths from cancer (thousands), ASRsa (per 100,000) by sex, cancer site, and age group in Europe for 2020.

Cancer Both
Males
Females
0–44
45–64
65+
0–44
45–64
65+
0–44
45–64
65+
Deaths % ASR Deaths % ASR Deaths % ASR Deaths % ASR Deaths % ASR Deaths % ASR Deaths % ASR Deaths % ASR Deaths % ASR
Lip, oral cavity and pharynx 18.6 3.8 0.5 241.6 5.0 11.6 278.6 2.0 19.4 14.8 6.8 0.7 204.0 7.2 20.4 195.4 2.5 33.1 3.8 1.4 0.2 37.6 1.9 3.4 83.2 1.3 9.6
Oesophagus 5.6 1.2 0.1 151.7 3.2 7.2 297.8 2.1 20.9 4.4 2.0 0.2 128.9 4.6 12.9 215.8 2.8 37.4 1.1 0.4 0.1 22.8 1.2 2.1 82.0 1.3 9.5
Stomach 24.9 5.1 0.6 248.3 5.2 11.8 696.8 4.9 48.6 12.4 5.7 0.6 172.9 6.1 17.2 409.3 5.3 71.7 12.5 4.6 0.6 75.4 3.8 6.9 287.5 4.5 33.0
Colorectum 29.4 6.0 0.7 463.3 9.7 22.0 1955.5 13.8 136.6 14.0 6.4 0.7 277.9 9.8 27.7 1027.0 13.3 183.5 15.5 5.7 0.8 185.5 9.4 16.9 928.5 14.5 106.0
Liver 10.9 2.2 0.3 201.0 4.2 9.6 572.2 4.0 40.1 7.2 3.3 0.4 151.4 5.4 15.1 354.9 4.6 62.3 3.7 1.4 0.2 49.7 2.5 4.5 217.3 3.4 25.0
Gallbladder 0.5 0.1 0.0 16.3 0.3 0.8 70.3 0.5 4.9 0.2 0.1 0.0 5.3 0.2 0.5 20.5 0.3 3.7 0.3 0.1 0.0 11.1 0.6 1.0 49.8 0.8 5.8
Pancreas 13.3 2.7 0.3 322.0 6.7 15.3 986.0 7.0 69.0 8.6 4.0 0.4 199.8 7.1 19.9 458.5 5.9 80.4 4.7 1.7 0.2 122.2 6.2 11.0 527.5 8.2 61.0
Larynx 3 0.6 0.1 79.3 1.7 3.8 113.7 0.8 7.9 2.6 1.2 0.1 72.2 2.6 7.2 101.3 1.3 17.3 0.5 0.2 0.0 7.1 0.4 0.6 12.3 0.2 1.4
Lung 31.3 6.4 0.8 1176.4 24.5 55.7 2634.1 18.6 184.7 18.3 8.4 0.9 823.1 29.2 81.9 1758.9 22.8 305.0 13.0 4.8 0.6 353.3 17.9 32.0 875.3 13.7 103.5
Melanoma of skin 18.5 3.8 0.5 70.7 1.5 3.4 174.4 1.2 12.2 10.0 4.6 0.5 41.4 1.5 4.1 95.7 1.2 17.0 8.5 3.2 0.4 29.3 1.5 2.7 78.7 1.2 9.0
Breast 67.6 25.1 3.3 381.8 19.3 35.2 968.3 15.1 111.6
Cervix uteri 41.0 15.2 2.0 107.3 5.4 10.0 111.6 1.7 13.1
Corpus uteri 3.3 1.2 0.2 69.6 3.5 6.3 226.8 3.5 26.5
Ovary 15.3 5.7 0.8 136.5 6.9 12.5 288.6 4.5 33.9
Prostate 0.7 0.3 0.0 89.4 3.2 8.9 990.8 12.8 184.0
Testis 8.3 3.8 0.4 3.8 0.1 0.4 3.5 0.0 0.6
Kidney 8.2 1.7 0.2 130.6 2.7 6.2 401.8 2.8 28.1 5.5 2.5 0.3 96.4 3.4 9.6 244.1 3.2 43.2 2.7 1.0 0.1 34.2 1.7 3.1 157.7 2.5 18.1
Bladder 2.2 0.5 0.1 80.3 1.7 3.8 590.4 4.2 41.2 1.2 0.6 0.1 63.4 2.2 6.3 443.5 5.7 81.1 1.0 0.4 0.0 16.9 0.9 1.5 146.8 2.3 16.5
Brain, central nervous system 59.4 12.2 1.5 196.3 4.1 9.4 281.1 2.0 19.7 36.4 16.8 1.8 116.0 4.1 11.6 141.3 1.8 24.3 23.0 8.5 1.1 80.3 4.1 7.4 139.8 2.2 16.5
Thyroid 1.2 0.2 0.0 13.5 0.3 0.6 49.3 0.3 3.4 0.6 0.3 0.0 6.7 0.2 0.7 16.4 0.2 2.9 0.6 0.2 0.0 6.8 0.3 0.6 33.0 0.5 3.8
Hodgkin lymphoma 8.3 1.7 0.2 10.2 0.2 0.5 21.0 0.1 1.5 5.1 2.3 0.2 6.7 0.2 0.7 11.0 0.1 1.9 3.2 1.2 0.2 3.6 0.2 0.3 10.0 0.2 1.2
Non-Hodgkin lymphoma 18.9 3.9 0.5 87.8 1.8 4.2 390.2 2.8 27.3 11.9 5.5 0.6 55.7 2.0 5.6 204.7 2.6 36.8 7.0 2.6 0.3 32.0 1.6 2.9 185.6 2.9 21.2
Multiple myeloma 1.8 0.4 0.0 56.1 1.2 2.7 267.1 1.9 18.7 1.1 0.5 0.1 31.5 1.1 3.1 138.4 1.8 24.9 0.7 0.3 0.0 24.6 1.2 2.2 128.7 2.0 14.9
Leukaemia 35 7.2 0.9 102.3 2.1 4.9 485.3 3.4 33.9 20.0 9.2 1.0 59.7 2.1 6.0 263.8 3.4 47.5 15.1 5.6 0.8 42.6 2.2 3.9 221.5 3.5 25.3
All sites excl. non-melanoma skin 486.9 12.0 4800.2 228.3 14138.4 988.3 217.3 10.6 2822.2 281.4 7726.3 1371.5 269.6 13.3 1977.9 180.6 6412.2 740.8
a

ASR = Age-standardised rates using European standard population 2013, based on estimated number of new cases.